Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:14 pm Purchase | 2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI | ACORN BIOVENTURES, L.P. | 3,940,052 8.000% | 660,612 (+20.14%) | Filing History |
| 2025-02-14 11:11 am Sale | 2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -2,631,713 (Position Closed) | Filing History |
| 2025-02-14 08:34 am Sale | 2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 0 0.000% | -2,805,000 (Position Closed) | Filing History |
| 2025-02-03 4:00 pm Sale | 2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Millennium Management LLC | 1,894,126 3.900% | -1,270,123 (-40.14%) | Filing History |
| 2024-11-14 12:12 pm Purchase | 2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI | ACORN BIOVENTURES, L.P. | 3,279,440 6.700% | 344,944 (+11.75%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 3,827,223 7.800% | 0 (Unchanged) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 3,827,223 7.800% | 1,924,086 (+101.10%) | Filing History |
| 2024-03-29 10:40 am Purchase | 2024-03-25 | 13G | Puma Biotechnology, Inc. PBYI | Frazier Life Sciences Public Fund, L.P. | 2,631,713 5.400% | 2,631,713 (New Position) | Filing History |
| 2024-02-14 08:19 am Sale | 2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,805,000 5.900% | -1,430,000 (-33.77%) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | Puma Biotechnology, Inc. PBYI | VANGUARD GROUP INC | 3,802,081 7.990% | 213,159 (+5.94%) | Filing History |
| 2024-02-06 3:54 pm Purchase | 2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI | ACORN BIOVENTURES, L.P. | 2,934,496 6.200% | 194,561 (+7.10%) | Filing History |
| 2024-01-30 4:08 pm Purchase | 2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Millennium Management LLC | 3,164,249 6.700% | 487,336 (+18.21%) | Filing History |
| 2023-09-01 10:18 am Purchase | 2023-08-22 | 13G | Puma Biotechnology, Inc. PBYI | ACORN BIOVENTURES, L.P. | 2,739,935 5.800% | 2,739,935 (New Position) | Filing History |
| 2023-02-14 08:30 am Purchase | 2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 4,235,000 9.280% | 2,185,000 (+106.59%) | Filing History |
| 2023-02-09 11:30 am Sale | 2022-12-30 | 13G | Puma Biotechnology, Inc. PBYI | VANGUARD GROUP INC | 3,588,922 7.860% | -91,265 (-2.48%) | Filing History |
| 2023-02-07 4:33 pm Sale | 2022-12-30 | 13G | Puma Biotechnology, Inc. PBYI | GOLDMAN SACHS GROUP INC GS | 396,136 0.900% | -1,701,511 (-81.12%) | Filing History |
| 2023-01-19 4:19 pm Purchase | 2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Millennium Management LLC | 2,676,913 5.800% | 439,214 (+19.63%) | Filing History |
| 2022-12-12 6:35 pm Purchase | 2022-12-09 | 13D | Puma Biotechnology, Inc. PBYI | AUERBACH ALAN H | 10,195,990 20.500% | 848,713 (+9.08%) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Puma Biotechnology, Inc. PBYI | BlackRock Inc. BLK | 1,903,137 4.200% | -1,301,100 (-40.61%) | Filing History |
| 2022-03-14 8:24 pm Purchase | 2022-03-10 | 13D | Puma Biotechnology, Inc. PBYI | AUERBACH ALAN H | 9,347,277 21.000% | 2,089,066 (+28.78%) | Filing History |